The treatment of hypertrophic scars and keloids

European Journal of Dermatology

Volumn 8, Issue 8, 1998, Pages 591-596

  Berman, Brian ^a   Flores, Francisco ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Carbon dioxide laser; Corticosteroids; Hypertrophic scars; Interferon; Keloids; Laser therapy; Pulsed dye laser; Radiotherapy; Scarring; Silicone sheeting

Indexed keywords

AZETIDINE DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; CORTICOSTEROID; DECORIN; DEXAMETHASONE; GAMMA INTERFERON; HYDROXYPROLINE; PENTOXIFYLLINE; PROLINE; SILICONE; TRANILAST; TRANSFORMING GROWTH FACTOR BETA;

CARBON DIOXIDE LASER; COMPRESSION THERAPY; CONTINUING EDUCATION; CORTICOSTEROID THERAPY; CRYOSURGERY; EXCISION; HUMAN; HYPERTROPHIC SCAR; IMMUNOTHERAPY; INTERSTITIAL RADIATION; INTRALESIONAL DRUG ADMINISTRATION; KELOID; LASER SURGERY; PULSED DYE LASER; REVIEW; SCAR FORMATION; WOUND DRESSING;

ADRENAL CORTEX HORMONES; CICATRIX, HYPERTROPHIC; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KELOID; MALE; PROGNOSIS; RADIOTHERAPY; SURGICAL PROCEDURES, OPERATIVE;

EID: 0032410066     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Breasted JH. The Edwin Smith surgical papyrus, vol. 1. Hieroglyphic translation and commentary. Chicago: University of Chicago Press, 1930: 403, 406.
2. Alibert JLM. Quelques recherches sur les cheloïdes. Mem Soc Médicale d'Emulation 1917: 744.
3. Berman B, Bieley HC. Keloids. J Am Acad Dermatol 1995; 33: 117-23.
4. Koonin AJ. The etiology of keloids: a review of the literature and a new hypothesis. South Afr Med J 1964; 38: 913-4.
5. Oluwasanmi JO. Keloids in the African. Clin Plast Surg 1974; 1: 179-95.
6. Castaqnoli C, Perveccio D, Stella M, et al. The HLA-DR beta 16 allogenotype constitutes a risk factor for hypertrophic scarring. Hum Immunol 1990; 29: 229-32.
7. Cohen IK, McCoy BJ, Moharakvmar T, et al. Immunoglobulin, complement, and histocompatability antigen studies in keloid patients. Plast Reconstr Surg 1979; 63: 689-95.
8. Blackburn WR, Cosman B. Histologic basis of keloid and hypertrophic scar differentiation. Arch Pathol 1966; 85: 65-71.
9. Knapp TR, Daniels JR, Kaplan EN. Pathologic scar formation. Am J Pathol 1977; 86: 47-69.
10. Kischer CW, Shetlar MR. Collagen and mucopolysaccharides in the hypertrophic scar. Conned Tissue Res 1974; 2: 205-13.
11. Kischer CW, Brody GS. Structure of the collagen nodule from hypertrophic scars and keloids. Scanning Microsc (Pt. 3) 1981: 371-6.
12. Kischer CW, Theis AC, Chvapil M. Perivascular myofibroblasts and microvascular occlusion in hypertrophic scar and keloids. Hum Pathol 1982: 13: 819-24.
13. Rockwell WB, Cohen IK, Ehrlich HP. Keloids and hypertrophic scars: a comprehensive review. Plast Reconstr Surg 1989; 84: 827-37.
14. Cohen IK, Keiser HR, Sjoerdsma A. Collagen synthesis in human keloid and hypertrophic scar. Surg Forum 1971; 22: 488-9.
15. Cohen IK, Beaven MA, Horakova Z, Keiser HR. Histamine and collagen synthesis in keloid and hypertrophic scar. Surg Forum 1972; 23: 509-10.
16. Craig RDP, Schofield JD Jackson DS. Collagen biosynthesis in normal human skin and hypertrophic scars and keloids as a function of the duration of the scar. Br J Surg 1975; 62: 741-4.
17. Craig RDP, Schofield JD Jackson DS. Collagen biosynthesis in normal human skin and hypertrophic scars and keloid. Eur J Clin Invest 1975; 5: 69-74.
18. Craig P. Collagenase activity in cutaneous scars. Hand 1973; 5: 239-46.
19. Aberpel RP, Pizzurrro D, Meeker CA, Lask G, Matsuoka LY, Minor RR, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol 1985; 84: 384-90.
20. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994; 30: 506-7.
21. Gold MH. Topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Dermatol Surg Oncol 1993; 19: 912-6.
22. Fulton JE. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg 1995; 21: 947-51.
23. Gold MH. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994; 30: 506-7.
24. Sawada Y, Sone K. Hydration and occlusion treatment for hypertrophic scars and keloids. Br J Plast Surg 1992; 45: 599-603
25. Bieley HC, Berman B. Effects of a water-impermeable, non-silicone-based occlusive dressing on keloids. J Am Acad Dermatol 1996; 35: 113-4.
26. Kischer CW, Shetlar MR, Shetlar CL. Alteration of hypertrophic scars induced by mechanical pressure. Arch Dermatol 1975; 111: 60-64.
27. Farrior RT, Stambaugh KI. Keloids and hyperplastic scars. In: Thomas JR, Holt GR, eds. Facial scars, revisions, and camouflage. St Louis, CV Mosby, 1989: 211-28.
28. Murray JC, Pinnell SR. Keloids and excessive dermal scarring. In: Cohen IK, Diegelman RF, Lindblod WS, (eds.) Wound healing: biochemical and clinical aspects. Philadelphia, WB Saunders, 1992: 500-9.
29. Snyder GB. Button compression for keloids of the lobule. Br J Plast Surg 1974; 27: 186-7.
30. Haq MA, Haq A. Pressure therapy in treatment of hypertrophic scar, burn and keloid: the Kenyan experience. East Afr Med J 1990: 785-91.
31. Brent B. The role of pressure therapy in management of earlobe keloids: preliminary report of a controlled study. Ann Plast Surg 1978; 1: 579-81.
32. Snyder GB. Button compression for keloids of the lobule. Br J Plast Surg 1974; 27: 186-7.
33. Goslen JB. The role or steroids in preventing scar formation. In: Thomas JR, Holt GR, eds. Facial scars, revisions, and camouflage. St Louis, CV Mosby, 1989: 83-97.
34. 2 laser treatment in hypertrophic and keloid scar. Laser Surg Med 1984; 3: 271-7.
35. Kantor GR, Wheeland RG, Bailin PL, et al. Treatment of earlobe keloids with carbon dioxide laser excision. A report of 16 cases. J Dermatol Surg 1985; 11:1063-7.
36. Peacock EE, Madden JW, Trier WC. Biologic basis for the treatment of keloids and hypertrophic scars. South Med J 1970; 63: 755-60.
37. Shepard JP, Dawber RPR. The response of keloids to cryosurgery. Plast Reconstr Surg 1982; 10: 677-81.
38. Conway H, Gillette RW, Smith JW, Findley A. Differential diagnosis of keloids and hypertrophic scars by tissue culture technique with notes on the therapy of keloids by surgical excision and Decadron. Plast Reconstr Surg 1960; 25: 117-21.
39. Lawrence WT. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg 1991; 27: 164-78.
40. Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol 1993; 19: 529-34.
41. Zouboulis CC, Blume U, Buttner P et al. Outcomes of cryosurgery in keloids and hypertrophic scars. A prospective consecutive trial of case series. Arch Dermatol 1993; 129: 1146-51.
42. Sherris DA, Larrabee WF, Murakami CS. Management of scar contractures, hypertrophic scars, and keloids. Otolaryngol Clin N Am 1995; 28: 1057-68.
43. Morris JEC. Superficial X-ray therapy in keloid management: a retrospective study of 24 cases and literature review. Plast Reconst Surg 1995; 95: 1051-6.
44. Van den Brenk HAS, Minty CCJ. Radiation in the management of hypertrophic scars and keloids. Br J Surg 1959; 47: 595-605.
45. Levitt WM, Gillies H. Radiotherapy in the prophylaxis and treatment of keloids. Lancet 1942; 1: 440-3.
46. Sclafani AP, Gordon L, Chadha M, Romo T. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy. Dermatol Surg 1996; 22: 569-74.
47. Cornbleet T. Treatment of keloids with hyaluronidase. JAMA 1954; 134: 1161-3.
48. Ship AG, Weiss PR, Mincer FR, et al. Sternal keloids: successful treatment employing sur?ery and adjunctive radiation. Ann Plast Surg 993; 31: 481-7.
49. Morris JCE. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 1991; 87: 44-9.
50. Morris JCE. The effect of carbon dioxide laser surgery on the recurrence of keloids. Plast Reconstr Surg 1991; 87: 50-3.
51. Stucker FJ, Shaw GY. An approach to management of keloids. Arch Otolaryngol Head Neck Surg 1992; 118: 63-7.
52. Gold MA. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol 1994; 30: 506-7.
53. Stern JC, Lucente FE. Carbon dioxide laser excision of earlobe keloids. A prospective study and critical analysis of existing data. Arch Otolaryngol Head Neck Surg 1989; 115: 1107-14.
54. 2 laser and cold steel surgical treatment of keloids give comparable results. Lasers Surg Med 1988; 8: 187.
55. Apfelberg DB, Maser MR White DN, et al. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med 1989; 9: 382-8.
56. Sherman R, Rosenfeld H. Experience with the Nd:YAG laser in the treatment of keloid scars. Ann Plast Surg 1988; 24: 231-3.
57. Henning JPH, Roskam Y, van Gemert MJC. Treatment or keloids and hypertrophic scars with an argon laser. Lasers Surg Med 1986, 6: 72-5.
58. Henderson DL, Cromwell TA, Mes LG. Argon and carbon dioxide laser treatment of hypertrophie and keloid scars. Lasers Surg Med 1984; 3: 271-7.
59. Alster TS, Williams C. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser, Lancet 1995; 345: 1198-200.
60. Berman B, Duncan MR. Short-term keloid treatment in vivo with human interferon-α2a results in a selective and persistent normalization of keloid fibroblast collagen, glycosaminoglycan and collagenase production in vitro. J Am Acad Dermatol 1989; 21: 694-706.
61. Granstein RD, Rook A, Flotte TJ, Haas A Gallo RL, Jaffe HS, et al. A controlled trial of intralesional recombinant interferon-γ in the treatment of keloidal scarring. Arch Dermatol 1990; 126: 1295-301.
62. Larrabe WF, East CA, Jaffe HS, Stepheson C, Peterson KE. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990; 116: 1159-62.
63. Berman B, Flores F. Recurrence rates of excised keloids treated with postoperative triamcinolone acetonide injections or interferon alfa-2b injections. J Am Acad Dermatol 1997; 37: 755-7.
64. Low SZ, Moy RL. Scar war strategies. Target collagen. J Dermatol Surg Oncol 1992; 18: 981-6.
65. Tan EML, Ryhanen L, Uitto J. Praline analogues inhibit human skin fibroblast growth collagen production in culture. J Br Dermatol 1983; 80: 261-7.
66. Swzawa H, Kikuchi S, Ichikawa K. Effect of tranilast, an anti-allergic drug, on the human keloid tissues. Nip Yakurigaku ZasshiFolia Pharmacoloqica Japonica 1992; 99: 231-9.
67. Berman B, Duncan MR. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol 1989; 92: 605-10.
68. Berman B, Duncan MR. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphea skin and their production of collagen, glycosaminoglycan and fibronectin. Br J Dermatol 1990, 123: 339-46.
69. Border WA, Nobel NA. Transforming growth factor R in tissue fibrosis. N Engl J Med 1994; 331: 1286-92.